Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers

Table 2 Sites of relapse or metastasis

Site	Number	%
Local relapse	5	12
Bone*	17	41
Liver	4	10
Lung	34	81
Lymph nodes	8	19
Brain	1	2
Other sites	3	7
25 patients (60%) with at least 2 metastatic sites

* All patients with metastatic bone disease received bisphosphonate treatment (ibadronate or zoledronate). Eleven patients needed radiotherapy to the metastatic bone disease and three required an operation as well.

ISSN: 1471-2407